Quote:
Originally Posted by Steve G  Surely the licencing wouldn't be different unless there was a good reason for it, |
The patent on Penbritin was soon to expire and its replacement Amoxil needed to offer an advantage in order to generate sales.
Quote:
|
and given that amoxicillin is effective at a tds dose, why give it qds?
|
No reason at all, but neither expensive nor dangerous enough to worry about.
Jeff